Union Health Minister Dr Masnukh Mandviya on Thursday met World Health Organisation Chief Scientist Soumya Swaminathan. During the meeting, Mandaviya discussed the WHO’s approval for Bharat Biotech’s Covid-19 vaccine ‘Covaxin’.
“Held a meeting with Dr Soumya Swaminathan, Chief Scientist of @WHO We had a productive discussion on WHO’s approval of @BharatBiotech ’s COVAXIN. @DoctorSoumya also appreciated India’s efforts for the containment of #COVID19,” tweeted the Health Minister.
The Indian vaccine has also been approved in Hungary but is looking for the approval of the global health body which could make it easy for the vaccine to be approved in several other countries.
Canadian authorities are currently examining the data of the vaccine Ocugen, the US and Canada partner of Bharat Biotech said last week.
However, the Indian Council of Medical Research (ICMR) has said that mixing dosesAfter this of Covishiled and Covaxin will generate stronger immunity.
A study by the ICMR involving 98 people, 18 of whom had inadvertently received Covishield as the first dose and Covaxin as the second in Uttar Pradesh, showed that combining these two Covid-19 vaccines elicited better immunogenicity than two doses of the same vaccine.
Following this Central Drugs Standard Control Organisation (CDSCO), India’s drug regulator approved a study to be conducted by the Christian Medical College (CMC), Vellore on the mixing of Covid-19 vaccines Covaxin and Covishield, official sources said on Wednesday.
The trial will involve 300 healthy volunteers. “The aim of the study is to assess the feasibility on whether a person can be given two different vaccine shots- one each of Covishield and Covaxin- to complete the inoculation course,” a source said.